A LAGging kiss leaves T cells cold.

Area of Science:

• Immunology
• Molecular Biology
• Cellular Biology

Background:

• Lymphocyte-activation gene 3 (LAG-3) is a cell surface receptor expressed on activated immune cells.
• LAG-3 plays a crucial role in regulating T cell responses and maintaining immune homeostasis.
• Dysregulation of LAG-3 function is implicated in various pathological conditions, including cancer and autoimmunity.

Purpose of the Study:

• To elucidate the molecular mechanisms by which LAG-3 modulates CD4+ T cell activation.
• To investigate the role of CDε-Lck condensates in LAG-3-mediated T cell suppression.
• To validate LAG-3 as a potential therapeutic target for immune-related diseases.

Main Methods:

• Co-immunoprecipitation assays to study protein-protein interactions.
• Confocal microscopy to visualize CDε-Lck condensate formation.
• Flow cytometry to assess CD4+ T cell activation markers.
• In vitro assays using T cell lines and primary immune cells.

Main Results:

• LAG-3 was found to directly interact with CDε-Lck condensates.
• Disruption of CDε-Lck condensates by LAG-3 leads to the dampening of CD4+ T cell activation.
• Inhibition of LAG-3 function restored T cell activation in a preclinical model.

Conclusions:

• LAG-3 negatively regulates CD4+ T cell activation through the disruption of CDε-Lck condensates.
• Targeting LAG-3 offers a promising therapeutic strategy for enhancing anti-tumor immunity and managing autoimmune disorders.